Skip to main content

Articles

Page 4 of 12

  1. The effect of tonsillectomy with adenoidectomy (T&A) on otitis media has been investigated, but there have been no reports of the relationship between T&A and medical services used in association with otitis m...

    Authors: Junhui Jeong, Jung Kyu Choi, Jae Sung Nam, Hyang Ae Shin, Jung Hyun Chang and Hyun Seung Choi
    Citation: Cost Effectiveness and Resource Allocation 2020 18:48
  2. Cost-effectiveness analysis provides a crucial means for evidence-informed decision-making on resource allocation. This study aims to elicit individuals' willingness to pay (WTP) for one additional quality-adj...

    Authors: Najmeh Moradi, Abraha Woldemichael, Parisa Malekian, Delnia Moradi Rotvandi and Satar Rezaei
    Citation: Cost Effectiveness and Resource Allocation 2020 18:47
  3. During the past 20 years, Iran has been experiencing a significant increase in the occurrence of disasters mainly due to the emergence of anthropogenic climate change. This paper aims at analyzing the trend of...

    Authors: Hamed Seddighi and Sadegh Seddighi
    Citation: Cost Effectiveness and Resource Allocation 2020 18:46
  4. Pharmacists hold to their promise to foster, implement and promote the health of the population and to prevent disease, given their knowledge, skills, and proximity to the locals. The objective of this study w...

    Authors: Che-huei Lin, Ya-Wen Lin, Jong-yi Wang and Ming-hung Lin
    Citation: Cost Effectiveness and Resource Allocation 2020 18:45
  5. To compare costs and outcomes following knee chondroplasty with Coblation versus mechanical shaver debridement (MSD) in patients with grade III articular cartilage lesions of the knee.

    Authors: Ayoade Adeyemi, Leo Nherera, Paul Trueman and Anil Ranawat
    Citation: Cost Effectiveness and Resource Allocation 2020 18:44
  6. The implementation of public policies requires special attention from public authorities to ensure their transparency, effectiveness and efficiency. For this reason, efforts to evaluate the abovementioned poli...

    Authors: Krzysztof Kaczmarek and Piotr Romaniuk
    Citation: Cost Effectiveness and Resource Allocation 2020 18:43
  7. Patients with infantile-onset spinal muscular atrophy (SMA), a rare, genetic neuromuscular disease, do not achieve key motor function milestones (e.g., sitting) and have short life expectancy in the absence of...

    Authors: Praveen Thokala, Matt Stevenson, Varun M. Kumar, Shijie Ren, Alexandra G. Ellis and Richard H. Chapman
    Citation: Cost Effectiveness and Resource Allocation 2020 18:41
  8. Compared to other countries in the South Asia Nepal has seen a slow progress in the coverage of health insurance. Despite of a long history of the introduction of health insurance (HI) and a high priority of t...

    Authors: Chhabi Lal Ranabhat, Radha Subedi and Sujeet Karn
    Citation: Cost Effectiveness and Resource Allocation 2020 18:40
  9. Cardiovascular diseases have the highest mortality rates and the costs for treatment are very high so far. Cardiovascular rehabilitation helps to reduce the risk of relapses or deterioration of cardiovascular ...

    Authors: Ondřej Gajdoš, Vojtěch Kamenský, Kristýna Doskočilová, Martina Caithamlová and Ivana Kubátová
    Citation: Cost Effectiveness and Resource Allocation 2020 18:39
  10. the health service tariff is an appropriate policymaking tool and the financial leverage of the health system control which affects quality, availability, cost, efficiency, equity and accountability of health ...

    Authors: Ali Aboutorabi, Maryam Radinmanesh, Aziz rezapour, Mahnaz afshari and Ghasem taheri
    Citation: Cost Effectiveness and Resource Allocation 2020 18:38
  11. Increase in total health expenditures is one of the main challenges of health systems worldwide, and its inequality is considered as a concern in global arena especially developing countries. This study aims t...

    Authors: Mohammad Hossein Mehrolhassani, Vahid Yazdi-Feyzabadi and Marzieh Lashkari
    Citation: Cost Effectiveness and Resource Allocation 2020 18:37
  12. The rate of catastrophic health expenditure (CHE) continues to rise in South Korea. This study examined the association between changes in economic activity and CHE experiences in South Korea.

    Authors: Hyeon Ji Lee, Doo Woong Lee, Dong-Woo Choi, Sarah Soyeon Oh, Junhyun Kwon and Eun-Cheol Park
    Citation: Cost Effectiveness and Resource Allocation 2020 18:36
  13. Different classification of hospitals (COH) have an important impact on medical expenditures in China. The objective of this study is to examine the impact of COH on medical expenditures with the hope of provi...

    Authors: Lele Li, Tiantian Du and Yanping Hu
    Citation: Cost Effectiveness and Resource Allocation 2020 18:35
  14. Globally, there is a consensus to end the HIV/AIDS epidemic by 2030, and one of the strategies to achieve this target is that 90% of people living with HIV should know their HIV status. Even if there is strong...

    Authors: Amanuel Yigezu, Senait Alemayehu, Shallo Daba Hamusse, Getachew Teshome Ergeta, Damen Hailemariam and Alemayehu Hailu
    Citation: Cost Effectiveness and Resource Allocation 2020 18:34
  15. This study aimed to examine the cost-effectiveness of one-time standard endoscopic screening with Lugol’s iodine staining for esophageal cancer (EC) in China.

    Authors: Yuanyuan Li, Lingbin Du, Youqing Wang, Yuxuan Gu, Xuemei Zhen, Xiaoqian Hu, Xueshan Sun and Hengjin Dong
    Citation: Cost Effectiveness and Resource Allocation 2020 18:33
  16. This paper addresses the question of what a reasonable price for an orphan drug is. The research proposes a way to adjust an established payer/HTA body incremental cost-effectiveness threshold (CET) to take ac...

    Authors: Mikel Berdud, Michael Drummond and Adrian Towse
    Citation: Cost Effectiveness and Resource Allocation 2020 18:31
  17. Streptococcus pneumoniae (S. pneumoniae) and non-typeable Haemophilus influenzae (NTHi) are substantial contributors to morbidity and mortality of diseases including invasive pneumococcal diseases (IPDs), pneumon...

    Authors: Chun-Yi Lu, Ching-Hu Chung, Li-Min Huang, Eliza Kruger, Seng-Chuen Tan, Xu-Hao Zhang and Nan-Chang Chiu
    Citation: Cost Effectiveness and Resource Allocation 2020 18:30

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2021 19:30

  18. Although the choice of the comparator is one of the aspects with a highest effect on the results of cost-effectiveness analyses, it is one of the less debated issues in international methodological guidelines....

    Authors: José Antonio Sacristán, José-María Abellán-Perpiñán, Tatiana Dilla, Javier Soto and Juan Oliva
    Citation: Cost Effectiveness and Resource Allocation 2020 18:29
  19. When patient health state transition evidence is missing from clinical literature, analysts are inclined to make simple assumptions to complete the transition matrices within a health economic model. Our aim w...

    Authors: Zoltán Vokó, István Bitter, Beatrix Mersich, János Réthelyi, Anett Molnár, János G. Pitter, Árpád Götze, Margit Horváth, Kristóf Kóczián, Laura Fonticoli, Filippo Lelli and Bertalan Németh
    Citation: Cost Effectiveness and Resource Allocation 2020 18:28
  20. Prior cost-effectiveness studies of post-mastectomy radiotherapy (PMRT) only compared conventional radiotherapy versus no radiotherapy and only considered tumor control. The goal of this study was to perform c...

    Authors: Yibo Xie, Beibei Guo and Rui Zhang
    Citation: Cost Effectiveness and Resource Allocation 2020 18:26
  21. In recent decades, many countries have utilized public–private partnership (PPP) as a development initiative to reform their healthcare sectors. The present study examines the feasibility of implementing publi...

    Authors: Ahmad Sadeghi, Omid Barati, Peivand Bastani, Davood Daneshjafari and Masoud Etemadian
    Citation: Cost Effectiveness and Resource Allocation 2020 18:25
  22. A cluster randomised controlled trial (cRCT) performed from July 2018 to March 2019 demonstrated the clinical impact of a community pharmacist delivered minor ailment service (MAS) compared with usual pharmaci...

    Authors: Sarah Dineen-Griffin, Constanza Vargas, Kylie A. Williams, Shalom I. Benrimoj and Victoria Garcia-Cardenas
    Citation: Cost Effectiveness and Resource Allocation 2020 18:24
  23. Hepatitis B virus (HBV) infection is an important cause of morbidity and mortality with a very high burden in Africa. The risk of developing chronic infection is marked if the infection is acquired perinatally...

    Authors: Solomon Tessema Memirie, Hailemichael Desalegn, Mulugeta Naizgi, Mulat Nigus, Lisanu Taddesse, Yared Tadesse, Fasil Tessema, Meseret Zelalem and Tsinuel Girma
    Citation: Cost Effectiveness and Resource Allocation 2020 18:23
  24. Nigeria health sector, like that of other sub-Saharan African countries, increasingly faces critical resource constraints. Thus, there is need to seek for ways of improving efficient use of scarce health resou...

    Authors: Henry E. Aloh, Obinna E. Onwujekwe, Obianuju G. Aloh and Chijioke J. Nweke
    Citation: Cost Effectiveness and Resource Allocation 2020 18:21
  25. Building upon decades of continuous reforms, Iran has been implementing various initiatives to reach universal health coverage (UHC). Improving efficiency is a crucial intermediate policy objective for UHC. Th...

    Authors: Haniye Sadat Sajadi, Zahra Goodarzi, Amirhossein Takian, Efat Mohamadi, Alireza Olyaeemanesh, Farhad Hosseinzadeh Lotfi, Hamid Sharafi, Somayeh Noori Hekmat, Matthew Jowett and Reza Majdzadeh
    Citation: Cost Effectiveness and Resource Allocation 2020 18:20
  26. Over 300,000 cataract operations are performed in Poland every year, and the most common, late complication of cataract removal surgery is posterior capsule opacification (PCO). The risk of PCO depends on the ...

    Authors: Monika Raulinajtys-Grzybek, Iwona Grabska-Liberek, Aleksandra Opala, Marta Słomka and Michał Chrobot
    Citation: Cost Effectiveness and Resource Allocation 2020 18:19
  27. Health systems are under pressure to deliver more effective care without expansion of resources. This is particularly pertinent to diseases like chronic kidney disease (CKD) that are exacting substantial finan...

    Authors: Sameera Senanayake, Nicholas Graves, Helen Healy, Keshwar Baboolal and Sanjeewa Kularatna
    Citation: Cost Effectiveness and Resource Allocation 2020 18:18
  28. Catastrophic health expenditures (CHE) are of concern to policy makers and can prevent individuals accessing effective health care services. The exposure of households to CHE is one of the indices used to eval...

    Authors: Leila Doshmangir, Mahmood Yousefi, Edris Hasanpoor, Behzad Eshtiagh and Hassan Haghparast-Bidgoli
    Citation: Cost Effectiveness and Resource Allocation 2020 18:17
  29. Diabetic retinopathy (DR) is a significant global public health and economic burden. DR accounts for approximately 15–17% of all cases of total blindness in the USA and Europe. Telemedicine is a new interventi...

    Authors: Daniel Avidor, Anat Loewenstein, Michael Waisbourd and Amir Nutman
    Citation: Cost Effectiveness and Resource Allocation 2020 18:16
  30. Since its inception in 2003, Cost Effectiveness and Resource Allocation journal has come a long way over the past 18 years. Possibly much longer than many of its contemporaries in the blossoming science of health...

    Authors: Mihajlo Jakovljevic, Klazien Matter-Walstra, Takuma Sugahara, Tarang Sharma, Vladimir Reshetnikov, Joav Merrick, Tetsuji Yamada, Sitaporn Youngkong and Joan Rovira
    Citation: Cost Effectiveness and Resource Allocation 2020 18:15
  31. In health care interventions aimed at increased physical activity, the individual’s time spent on exercise is a substantial input. Time costs should therefore be considered in cost-effectiveness analyses. The ...

    Authors: Lars Hagberg, Stefan Lundqvist and Lars Lindholm
    Citation: Cost Effectiveness and Resource Allocation 2020 18:14
  32. The 2014–2016 Ebola virus disease (EVD) outbreak in West Africa was the largest EVD outbreak recorded, which has triggered calls for investments that would facilitate an even earlier response. This study aims ...

    Authors: Klas Kellerborg, Werner Brouwer and Pieter van Baal
    Citation: Cost Effectiveness and Resource Allocation 2020 18:13
  33. To investigate the long-term economic outcome of dapagliflozin versus metformin in Chinese patients with type 2 diabetes mellitus (T2DM) whose diet and exercise have not provided sufficient glycemic control.

    Authors: Hua Nian, Xu Wan, Jing Ma, Fu Jie and Bin Wu
    Citation: Cost Effectiveness and Resource Allocation 2020 18:12
  34. Decision-making in public health and health policy is complex and requires careful deliberation of many and sometimes conflicting normative and technical criteria. Several approaches and tools, such as multi-c...

    Authors: J. M. Stratil, R. Baltussen, I. Scheel, A. Nacken and E. A. Rehfuess
    Citation: Cost Effectiveness and Resource Allocation 2020 18:8
  35. Anthracycline-treated childhood cancer survivors are at higher risk of cardiotoxicity, especially with cumulative doses received above 250 mg/m2. Dexrazoxane is the only option recommended for cardiotoxicity prev...

    Authors: Sarah Dewilde, Kevin Carroll, Emilia Nivelle and James Sawyer
    Citation: Cost Effectiveness and Resource Allocation 2020 18:7
  36. Please note that following publication of the original article [1], two errors have been flagged by the authors. Firstly, the article has been processed with the wrong article type: it is not a ‘Review’, but r...

    Authors: Ahmed D. Alatawi, Sayem Ahmed, Louis Niessen and Jahangir Khan
    Citation: Cost Effectiveness and Resource Allocation 2020 18:6

    The original article was published in Cost Effectiveness and Resource Allocation 2019 17:17

  37. Surveillance imaging is used to detect local and/or distant recurrence following primary treatment of localised soft tissue sarcoma (STS), however evidence supporting optimal surveillance modality or frequency...

    Authors: Susie Bae, Jonathan Karnon, Glenis Crane, Taryn Bessen, Jayesh Desai, Phillip Crowe and Susan Neuhaus
    Citation: Cost Effectiveness and Resource Allocation 2020 18:5
  38. Health Transformation Plan (HTP) was occurred in 2014 to improve access and equity and reduce out of pocket payments in Iranian Health Care System. In this regard the aim of this study is evaluating and rankin...

    Authors: Payam Shojaei, Najmeh bordbar, Arash Ghanbarzadegan, Maryam Najibi and Peivand Bastani
    Citation: Cost Effectiveness and Resource Allocation 2020 18:4
  39. Forty-nine million people or 83 per cent of the entire population of 59 million rely on the public healthcare system in South Africa. Coupled with a shortage of medical professionals, high migration, inequalit...

    Authors: Victor Ngobeni, Marthinus C. Breitenbach and Goodness C. Aye
    Citation: Cost Effectiveness and Resource Allocation 2020 18:3
  40. Pembrolizumab has been shown to improve overall survival (OS) and progression free survival (PFS) compared to ipilimumab in patients with ipilimumab-naïve advanced melanoma; however, there are no published dat...

    Authors: Herbert H. Loong, Carlos K. H. Wong, Linda K. S. Leung, S. C. Tan, Jason Jen, Mary Y. K. Lee, Raquel Aguiar-Ibáñez and Jingshu Wang
    Citation: Cost Effectiveness and Resource Allocation 2020 18:2
  41. Stereotactic body radiotherapy (SBRT) is a novel noninvasive treatment for hepatocellular carcinoma. SBRT can achieve effective local control, but it requires a relatively high input of resources; this systema...

    Authors: Haiyin Wang, Chunlin Jin, Liang Fang, Hui Sun, Wendi Cheng and Shanlian HU
    Citation: Cost Effectiveness and Resource Allocation 2020 18:1
  42. Equity in health financing as one main aspect of health equity plays an essential role on the path toward universal health coverage. Out of pocket payment (OOP), a source with high share to total health expend...

    Authors: Mohsen Bayati, Mohammad Hossein Mehrolhassani and Vahid Yazdi-Feyzabadi
    Citation: Cost Effectiveness and Resource Allocation 2019 17:28
  43. To conduct an indirect treatment comparison of patients with high-volume mHSPC and a cost analysis between Abi-ADT and Doc-ADT therapies in China.

    Authors: Xin Hu, Shuli Qu, Xingxing Yao, Chaoyun Li, Yanjun Liu and Jianye Wang
    Citation: Cost Effectiveness and Resource Allocation 2019 17:27
  44. The World Health Organisation recommended dolutegravir (DTG)-based antiretroviral therapy (ART) regimens are available but not reimbursed through the public reimbursement system in China. The objective of this...

    Authors: Yogesh Suresh Punekar, Na Guo, Gabriel Tremblay, James Piercy, Tim Holbrook and Benjamin Young
    Citation: Cost Effectiveness and Resource Allocation 2019 17:26

Annual Journal Metrics